These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21371853)

  • 21. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
    Wong SM; King T; Boileau JF; Barry WT; Golshan M
    Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen.
    Kennecke HF; Olivotto IA; Speers C; Norris B; Chia SK; Bryce C; Gelmon KA
    Ann Oncol; 2007 Jan; 18(1):45-51. PubMed ID: 17030545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive lobular breast cancer: does grade matter?
    Margenthaler JA
    J Surg Res; 2011 Jul; 169(1):16-8. PubMed ID: 20850783
    [No Abstract]   [Full Text] [Related]  

  • 24. XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancer.
    Tengström M; Mannermaa A; Kosma VM; Hirvonen A; Kataja V
    Anticancer Res; 2014 Jun; 34(6):3031-7. PubMed ID: 24922669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis.
    Maishman T; Copson E; Stanton L; Gerty S; Dicks E; Durcan L; Wishart GC; Pharoah P; ; Eccles D
    Br J Cancer; 2015 Mar; 112(6):983-91. PubMed ID: 25675148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast Malignancies in Children: Presentation, Management, and Survival.
    Richards MK; Goldin AB; Beierle EA; Doski JJ; Goldfarb M; Langer M; Nuchtern JG; Vasudevan S; Gow KW; Javid SH
    Ann Surg Oncol; 2017 Jun; 24(6):1482-1491. PubMed ID: 28058544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer characteristics and survival differences between Maori, Pacific and other New Zealand women included in the Quality Audit program of Breast Surgeons of Australia and New Zealand.
    Campbell I; Scott N; Seneviratne S; Kollias J; Walters D; Taylor C; Roder D
    Asian Pac J Cancer Prev; 2015; 16(6):2465-72. PubMed ID: 25824782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of care with regard to surgical choice and application of adjuvant radiation therapy for preinvasive and early stage breast cancer in rural Appalachia.
    Freeman AB; Huang B; Dragun AE
    Am J Clin Oncol; 2012 Aug; 35(4):358-63. PubMed ID: 21422902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The consequence of undertreating breast cancer in the elderly.
    Gajdos C; Tartter PI; Bleiweiss IJ; Lopchinsky RA; Bernstein JL
    J Am Coll Surg; 2001 Jun; 192(6):698-707. PubMed ID: 11400963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer.
    Dawood S; Lei X; Litton JK; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM
    Clin Breast Cancer; 2012 Oct; 12(5):364-72. PubMed ID: 23040004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
    Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
    Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a model to predict breast cancer survival using data from the National Cancer Data Base.
    Asare EA; Liu L; Hess KR; Gordon EJ; Paruch JL; Palis B; Dahlke AR; McCabe R; Cohen ME; Winchester DP; Bilimoria KY
    Surgery; 2016 Feb; 159(2):495-502. PubMed ID: 26365950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
    Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
    Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base.
    Greif JM; Pezzi CM; Klimberg VS; Bailey L; Zuraek M
    Ann Surg Oncol; 2012 Oct; 19(10):3199-204. PubMed ID: 22766989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic analysis of survival in small breast cancers.
    Mustafa IA; Cole B; Wanebo HJ; Bland KI; Chang HR
    J Am Coll Surg; 1998 May; 186(5):562-9. PubMed ID: 9583697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: clinicopathological features, efficacy, and factors affecting survival.
    Ulas A; Kos T; Avci N; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
    Asian Pac J Cancer Prev; 2015; 16(4):1643-9. PubMed ID: 25743846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
    Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
    Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological features among patients with advanced human epidermal growth factor-2-positive breast cancer with prolonged clinical benefit to first-line trastuzumab-based therapy: a retrospective cohort study.
    Vaz-Luis I; Seah D; Olson EM; Wagle N; Metzger-Filho O; Sohl J; Litsas G; Burstein HJ; Krop IE; Winer EP; Lin NU
    Clin Breast Cancer; 2013 Aug; 13(4):254-63. PubMed ID: 23829891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the AJCC 8th prognostic system for breast cancer in an Asian healthcare setting.
    Wong RX; Wong FY; Lim J; Lian WX; Yap YS
    Breast; 2018 Aug; 40():38-44. PubMed ID: 29677569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.